Article
Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia.
Hematology (Amsterdam, Netherlands) - 1 Feb 2008
Palmisano Michela, Grafone Tiziana, Renzulli Matteo, Ottaviani Emanuela, Testoni Nicoletta, Paolini Stefania, Papayannidis Cristina, Baccarani Michele, Martinelli Giovanni
Abstract excerpt
Acute myeloid leukemia (AML) remains the most common form of leukemia and the most common cause of leukemia death. Although conventional chemotherapy can cure between 25 and 45% of AML patients, the majority of patients die after relapse or of complications associated with treatment. Thus, more specific and less toxic treatments for AML patients are needed, especially for elderly patients. An indispensable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.